Shou J - Search Results

1

CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.

Chen H, Liu Y, Cao C, Xi H, Chen W, Zheng W, Dong X, Zheng S, Li L, Ma J, Gao Y, Shou J. Chen H, et al. Among authors: shou j. Ann Transl Med. 2021 May;9(9):761. doi: 10.21037/atm-19-4511. Ann Transl Med. 2021. PMID: 34268374 Free PMC article.

2

[Clinical value of renal radionuclide imaging for diagnosis of urinary tract tumor].

Ma J, Shou J, Xiao Z. Ma J, et al. Among authors: shou j. Zhonghua Zhong Liu Za Zhi. 1995 May;17(3):199-201. Zhonghua Zhong Liu Za Zhi. 1995. PMID: 7656825 Chinese.

3

[Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].

Shou J, Wang M, Ma J. Shou J, et al. Zhonghua Zhong Liu Za Zhi. 2000 Jan;22(1):36-8. Zhonghua Zhong Liu Za Zhi. 2000. PMID: 11776593 Chinese.

4

[Adenocarcinoma of the urinary bladder: a report of 27 cases].

Shou J, Ma J, Xu B. Shou J, et al. Zhonghua Zhong Liu Za Zhi. 1999 Nov;21(6):461-3. Zhonghua Zhong Liu Za Zhi. 1999. PMID: 11776628 Chinese.

5

Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.

Qin SL, Chen XJ, Xu X, Shou JZ, Bi XG, Ji L, Han YL, Cai Y, Wei F, Ma JH, Wu M, Zhan QM, Wang MR. Qin SL, et al. Cancer Lett. 2006 Jul 18;238(2):230-9. doi: 10.1016/j.canlet.2005.07.010. Epub 2005 Aug 25. Cancer Lett. 2006. PMID: 16125302

6

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy.

Song Y, Du CX, Zhang W, Sun YK, Yang L, Cui CX, Chi YB, Shou JZ, Zhou AP, Li CL, Ma JH, Wang JW, Sun Y. Song Y, et al. Chin Med J (Engl). 2016 Mar 5;129(5):530-5. doi: 10.4103/0366-6999.177001. Chin Med J (Engl). 2016. PMID: 26904986 Free PMC article.

7

Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.

Liu C, Shi B, Hao C, Wang Q, Lv Q, Xing N, Shou J, Qu L, Gao Y, Qin C, Zhao J, Shou C. Liu C, et al. Among authors: shou c, shou j. Oncotarget. 2016 Jul 12;7(28):43432-43441. doi: 10.18632/oncotarget.9468. Oncotarget. 2016. PMID: 27223068 Free PMC article.

8

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.

Cao C, Bi X, Liang J, Li L, Zhang H, Xiao Z, Xiao Z, Tian J, Wang D, Guan K, Li C, Ma J, Zheng S, Shou J. Cao C, et al. Among authors: shou j. BMC Cancer. 2019 Feb 13;19(1):144. doi: 10.1186/s12885-019-5359-0. BMC Cancer. 2019. PMID: 30760245 Free PMC article.

9

Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients.

Wen L, Guo L, Zhang W, Li Y, Jiang W, Di X, Ma J, Feng L, Zhang K, Shou J. Wen L, et al. Among authors: shou j. Front Oncol. 2019 Jun 17;9:504. doi: 10.3389/fonc.2019.00504. eCollection 2019. Front Oncol. 2019. PMID: 31263677 Free PMC article.

10

Pre-operative risk factors predicting missed diagnosis of renal vein tumor thrombus in renal cell carcinoma: a retrospective cohort study.

Jiang W, Cao C, Shi H, Shou J, Wang D, Wen L, Li C, Ma J. Jiang W, et al. Among authors: shou j. Scand J Urol. 2020 Apr;54(2):128-134. doi: 10.1080/21681805.2020.1727007. Epub 2020 Feb 14. Scand J Urol. 2020. PMID: 32054374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters